Cargando…
PGD2 displays distinct effects in diffuse large B-cell lymphoma depending on different concentrations
Prostaglandin D2 (PGD2), an arachidonic acid metabolite, has been implicated in allergic responses, parasitic infection and tumor development. The biological functions and molecular mechanisms of PGD2 in diffuse large B-cell lymphoma (DLBCL) are still undefined. In this study, we firstly found the h...
Autores principales: | Hu, Shunfeng, Lu, Tiange, Shang, Juanjuan, Cai, Yiqing, Ding, Mengfei, Zhou, Xiangxiang, Wang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892043/ https://www.ncbi.nlm.nih.gov/pubmed/36725845 http://dx.doi.org/10.1038/s41420-023-01311-6 |
Ejemplares similares
-
Activation of STING by SAMHD1 Deficiency Promotes PANoptosis and Enhances Efficacy of PD-L1 Blockade in Diffuse Large B-cell Lymphoma
por: Cai, Yiqing, et al.
Publicado: (2023) -
P1210: TARGETING PTGDS AS A NOVEL THERAPEUTIC APPROACH IN PERIPHERAL T CELL LYMPHOMA THROUGH REGULATING IRON METABOLISM
por: Hu, Shunfeng, et al.
Publicado: (2023) -
Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphoma
por: Yu, Zhuoya, et al.
Publicado: (2023) -
α-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis
por: Cai, Yiqing, et al.
Publicado: (2023) -
KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo–YAP pathway
por: Chen, Xiaomin, et al.
Publicado: (2023)